These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3476477)

  • 1. Naloxone abolishes obsessive-compulsive behavior in Tourette's syndrome.
    Sandyk R
    Int J Neurosci; 1987 Jul; 35(1-2):93-4. PubMed ID: 3476477
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of naloxone in Tourette's syndrome.
    Sandyk R
    Ann Neurol; 1985 Sep; 18(3):367-8. PubMed ID: 3863543
    [No Abstract]   [Full Text] [Related]  

  • 3. Naloxone in Gilles de la Tourette's syndrome.
    Gadoth N; Gordon CR; Streifler J
    Ann Neurol; 1987 Apr; 21(4):415. PubMed ID: 3472487
    [No Abstract]   [Full Text] [Related]  

  • 4. Tourette's syndrome and treatment with clomipramine hydrochloride.
    Donahoe DH; Meador M; Fortune T; Llorena R
    W V Med J; 1991 Oct; 87(10):468-70. PubMed ID: 1767522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anorexia nervosa in a young man with Tourette's syndrome.
    Annibali JA; Kales JD; Tan TL
    J Clin Psychiatry; 1986 Jun; 47(6):324-6. PubMed ID: 3458703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome.
    Peterson BS
    J Clin Psychiatry; 1996; 57 Suppl 9():24-34. PubMed ID: 8823347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tourette's disorder and associated complex behaviors: a case report.
    McDougle CJ; Southwick SM; Rohrbaugh RM
    Yale J Biol Med; 1990; 63(3):209-14. PubMed ID: 2238716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fluvoxamine-induced frontal lobe syndrome in a patient with comorbid Gilles de la Tourette's syndrome and obsessive compulsive disorder.
    George MS; Trimble MR
    J Clin Psychiatry; 1992 Oct; 53(10):379-80. PubMed ID: 1429480
    [No Abstract]   [Full Text] [Related]  

  • 9. Disentangling the overlap between Tourette's disorder and ADHD.
    Spencer T; Biederman J; Harding M; O'Donnell D; Wilens T; Faraone S; Coffey B; Geller D
    J Child Psychol Psychiatry; 1998 Oct; 39(7):1037-44. PubMed ID: 9804036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The central role of magnesium deficiency in Tourette's syndrome: causal relationships between magnesium deficiency, altered biochemical pathways and symptoms relating to Tourette's syndrome and several reported comorbid conditions.
    Grimaldi BL
    Med Hypotheses; 2002 Jan; 58(1):47-60. PubMed ID: 11863398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gilles de la Tourette's syndrome: biochemical approaches.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():459-65. PubMed ID: 1070064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychopathologic aspects of the tic in Gilles de la Tourette's disease].
    Léger JM; Ranty Y
    Ann Med Psychol (Paris); 1969 Dec; 2(5):689-95. PubMed ID: 5267189
    [No Abstract]   [Full Text] [Related]  

  • 13. Recognition and management of Tourette's syndrome and tic disorders.
    Bagheri MM; Kerbeshian J; Burd L
    Am Fam Physician; 1999 Apr; 59(8):2263-72, 2274. PubMed ID: 10221310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.
    Müller-Vahl KR; Schneider U; Koblenz A; Jöbges M; Kolbe H; Daldrup T; Emrich HM
    Pharmacopsychiatry; 2002 Mar; 35(2):57-61. PubMed ID: 11951146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible genetic relationship exists between Tourette's syndrome and obsessive-compulsive disorder.
    Pauls DL; Leckman JF; Towbin KE; Zahner GE; Cohen DJ
    Psychopharmacol Bull; 1986; 22(3):730-3. PubMed ID: 3467387
    [No Abstract]   [Full Text] [Related]  

  • 16. Obsessive-compulsive disorder in Tourette's syndrome.
    Como PG
    Adv Neurol; 1995; 65():281-91. PubMed ID: 7872146
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroendocrine and behavioral effects of naloxone in Tourette syndrome.
    Chappell PB; Leckman JF; Riddle MA; Anderson GM; Listwack SJ; Ort SI; Hardin MT; Scahill LD; Cohen DJ
    Adv Neurol; 1992; 58():253-62. PubMed ID: 1414631
    [No Abstract]   [Full Text] [Related]  

  • 18. Patterns of response to acute naloxone infusion in Tourette's syndrome.
    van Wattum PJ; Chappell PB; Zelterman D; Scahill LD; Leckman JF
    Mov Disord; 2000 Nov; 15(6):1252-4. PubMed ID: 11104215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurosurgical treatment of severe obsessive-compulsive disorder associated with Tourette's syndrome.
    Kurlan R; Kersun J; Ballantine HT; Caine ED
    Mov Disord; 1990; 5(2):152-5. PubMed ID: 2325677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tic or compulsion?: it's Tourettic OCD.
    Mansueto CS; Keuler DJ
    Behav Modif; 2005 Sep; 29(5):784-99. PubMed ID: 16046664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.